SC
AZN icon

Siena Capital’s AstraZeneca AZN Stock Holding History

Siena Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6K Hold
56
– – ﹤0.01% 128
2022
Q2 		$7K Sell
56
-2
-3% -$262 ﹤0.01% 186
2022
Q1 		$8K Buy
+58
New +$6.96K ﹤0.01% 220

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Siena Capital's AZN Position: Q3 2022 in Review

Siena Capital held its AstraZeneca (AZN) position steady in Q3 2022 at 56 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #128.

Siena Capital first reported a position in AZN in Q1 2022 and has held it in 3 quarters since. The position peaked at $8K in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Siena Capital held 56 shares of AstraZeneca worth $6K as of Q3 2022.
  • Siena Capital left its AstraZeneca share count unchanged in Q3 2022.
  • AstraZeneca made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #128 holding.
  • Siena Capital first reported a position in AstraZeneca in Q1 2022 and has held it in 3 quarters since.
  • Siena Capital's AstraZeneca position peaked at $8K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.